Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Home
Online First
Editions
Editorial Board
Authors and Reviewers
Submissions and Author Guidelines
Peer Review Process
Reviewer Guidelines
Reviewers
2022
Mission and scope
Editorial Policy
Contact
Search
Register
Login
Home
/
Archives
/
Vol. 11 No. 3 (2020)
Vol. 11 No. 3 (2020)
Published:
2020-09-30
Editorial
The headache and adverse events due to the use of personal protective equipment to combat Covid-19
Erlene Roberta Ribeiro dos Santos (Author)
55-56
PDF
HTML
Review
The role of TRPM8 in the pathophysiology of migraine
Eduardo de Almeida Guimarães Nogueira, Yara Dadalti Fragoso (Author)
57-60
PDF
HTML
CGRP: from history to clinical application - A review
Afonso Henrique Aragao, Joel Sanabria Duarte, Daniel Benzecry Almeida, Ricardo Ramina (Author)
61-67
PDF
HTML
Case Report
Pseudotumor cerebri secondary to secondary hypoparathyroidism and association to Fahr´s Syndrome: a case report
Patrick Giordanni Gomes Sampaio, Hiago Diniz Maracajá, Francielle Lopes de Araújo Batista, Virgínia Gabriela Nóbrega Figueiredo, Nátalia Meg Adijuto de Melo (Author)
68-71
PDF
HTML
Original
A framework for decision making of migraine treatment with anti- CGRP monoclonal antibodies: a guide for real-world practice and public policies
Reinilza Nunes da Gama, Thaiza Agostini Córdoba de Lima, Iron Dangoni Filho, Mario Fernando Prieto Peres (Author)
72-76
PDF
HTML
Commented Article
Anti-CGRP monoclonal antibodies in chronic cluster headache
Aline Turbino Neves Martins da Costa (Author)
77
PDF
HTML
Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans
Fabíola Dach Éckeli (Author)
78
PDF
HTML
Language
English
Português (Brasil)
Make a Submission
Make a Submission
Style
REFERENCES STYLE
Keywords